Viewing Study NCT00562159



Ignite Creation Date: 2024-05-05 @ 6:54 PM
Last Modification Date: 2024-10-26 @ 9:38 AM
Study NCT ID: NCT00562159
Status: COMPLETED
Last Update Posted: 2017-03-03
First Post: 2007-11-20

Brief Title: Efficacy and Safety of Grass Sublingual Tablet in Adults P05238 AM3COMPLETED
Sponsor: ALK-Abelló AS
Organization: ALK-Abelló AS

Study Overview

Official Title: A Multicenter Double-Blind Randomized Placebo-Controlled Parallel-Group Study Evaluating the Efficacy and Safety of Grass Phleum Pratense Sublingual Tablet SCH 697243 in Adult Subjects With a History of Grass Pollen Induced Rhinoconjunctivitis With or Without Asthma
Status: COMPLETED
Status Verified Date: 2017-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This purpose of this study is to determine the efficacy and safety of a grass sublingual under-the-tongue tablet
Detailed Description: This is a multicenter double-blind randomized placebo-controlled parallel-group study in participants 18 to 65 years of age of either sex and of any race with a history of grass pollen induced rhinoconjunctivitis with or without asthma While receiving treatment participants will receive either grass sublingual tablet or placebo Open-label rescue medications for the hinoconjunctivitis and asthma symptoms will be provided Participants will visit the study site for at least 12 visits A total of 10 allergic symptoms 6 rhinoconjunctivitis and 4 lung symptoms will be recorded daily on an electronic diary by the participant

The start and end of the grass pollen season GPS was determined based on the regional grass pollen count and lasted up to 162 days For each region the GPS is defined as the first day of 3 consecutive recorded days with a grass pollen count of 10 grainsm3 to the last day of the last occurrence of 3 consecutive recorded days with a grass pollen count 10 grainsm3 inclusively

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
3727105 None None None